Stock NEXI NEXIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. NexImmune, Inc.

Equities

NEXI

US65344D2080

Market Closed - Nasdaq
Other stock markets
 21:00:00 02/05/2024 BST 		5-day change 1st Jan Change
3.12 USD -1.89% Intraday chart for NexImmune, Inc. -8.50% +40.54%
04-17 North American Morning Briefing : Stock Futures -2- DJ
04-16 NexImmune, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Raymond James Downgrades NexImmune to Market Perform From Outperform
MT
Raymond James Adjusts NexImmune's Price Target to $3 from $12, Maintains Outperform Rating
MT
Barclays Cuts Price Target on NexImmune to $2 From $7, Keeps Overweight Rating
MT
Cantor Fitzgerald Adjusts Price Target for NexImmune to $4 From $35, Maintains Overweight
MT
BTIG Starts NexImmune at Buy With $5 Price Target
MT
Barclays Raises NexImmune's Price Target to $7 From $4, Maintains Overweight Rating
MT
Raymond James Adjusts NexImmune's Price Target to $13 from $21, Maintains Outperform Rating
MT
Raymond James Adjusts Price Target on NexImmune to $21 From $30, Keeps Outperform Rating
MT
NEXIMMUNE : Raymond James Initiates Coverage on NexImmune With Outperform Rating, $30 Price Target
MT
NEXIMMUNE : Cantor Fitzgerald Starts NexImmune at Overweight With $35 Price Target
MT
NEXIMMUNE : Barclays Starts NexImmune at Overweight With $35 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NEXI Stock
  4. News NexImmune, Inc.
  5. Analyst Reco.